• Sat. Jan 16th, 2021

Dimancherouge

Technology

Alivio

  • Home
  • Alivio Therapeutics Awarded $3.3 Million from U.S. Department of Defense

Alivio Therapeutics Awarded $3.3 Million from U.S. Department of Defense

Award will support advancement of ALV-304 into the clinic for the potential treatment of inflammatory bowel disease Alivio Therapeutics, a biotechnology company developing an inflammation-targeting disease immunomodulation platform for the…